The mammography
industry is projected to grow from USD 2.73 Billion in 2023 to USD 5.54 Billion
by 2032, exhibiting a compound annual growth rate (CAGR) of 9.25% during the
forecast period (2023 - 2032).
The mammography
market continues its upward trajectory, driven by
heightened awareness of breast cancer screening and advancements in imaging
technology. With a focus on early detection, digital mammography systems
dominate the market, offering superior image quality and reduced radiation
exposure. Growing investments in healthcare infrastructure, particularly in
emerging economies, further propel market expansion. Additionally, the rise of
3D mammography and AI-driven diagnostic tools enhances accuracy and efficiency
in detecting abnormalities. Market players are increasingly investing in
R&D to develop innovative solutions, aiming to improve patient outcomes and
streamline workflow for healthcare providers. Overall, the mammography market
shows promising growth prospects globally.
The Mammography
Market is witnessing a transformative shift with the advent of cutting-edge
technologies such as Digital Mammography and Solaris Mammogram systems. Digital
mammography, a revolutionary imaging technique, offers enhanced clarity and
accuracy in breast cancer detection compared to traditional film-based methods.
This advancement has significantly improved early diagnosis rates, thereby
saving countless lives worldwide.
Solaris Mammogram,
another groundbreaking innovation, integrates state-of-the-art solar technology
into mammography systems, enabling energy-efficient operations and reducing
environmental impact. The Solaris Mammogram technology underscores a commitment
to sustainability while ensuring top-tier diagnostic capabilities for
healthcare providers.
The integration
of Digital Mammography and Solaris Mammogram systems into healthcare facilities
has propelled the market forward, driving demand for advanced mammography
solutions globally. Healthcare institutions are increasingly adopting these
technologies to offer superior diagnostic services and improve patient
outcomes.
Key players in
the Mammography Market are investing heavily in research and development to
enhance the performance and accessibility of digital and solaris mammogram
systems. As a result, the market is poised for substantial growth in the coming
years, driven by technological advancements, rising cancer prevalence, and
growing awareness about the importance of early detection.
Segmentation
Analysis
The global mammography market is segmented
by technology and application.
By technology, it is segmented into analog,
digital mammography, C-view 2D, 3D mammography, breast tomosynthesis contrast
enhance tomography, and others. Digital mammography held the largest market
share due to preference of the technology for converting mammographic pictures
into digital images. 3D mammography is expected to be the largest segment by
2022 due to the capacity of the technology for pinpointing breast lesions and
reduce the large number of breast cancer cases. The technology can capture
images of the breast from different angles to give clinicians and doctors for
rapid diagnosis of patients. According to the Radiological Society of North
America, 3D mammography or digital breast tomosynthesis (DBT) can significantly
reduce breast biopsy rates.
By application, it is segmented into
diagnostic, screening, and others. The screening segment is likely to garner
significant revenue due to high cases of cancer among women. Reduction of
detection challenges due to adoption of DBT and digital mammography can drive
segment growth.
Region Analysis
Geographically, the mammography system
market comprises Asia Pacific, Americas, the Middle East & Africa, and
Europe.
Within Americas, North America is expected
to be the leading region in the global mammography market till 2022. The
Americas can exhibit a superb growth rate during the forecast period due to
adoption of latest technology, advanced healthcare infrastructure, and presence
of major companies. Increasing government support for research and development
can spur market growth.
APAC can grow at a swift pace due to
presence of developing economies of China and India and huge patient pool.
According to a report by Pfizer, a leading pharmaceutical company, 6.7 million
cancer cases were registered in 2012. High prevalence of breast cancer combined
with leading number of working women as well as initiatives by nations to
introduce screening and diagnostic camps can work favorably for the market.
The Europe region is predicted to be the
second-largest region after North America due to Germany and the U.K.
Within MEA, the Middle East is the biggest
contributor to the market due to huge healthcare spending and presence of
booming economies.
Competitive
Landscape
The mammography companies include Siemens Healthcare
GmbH, Carestream Health, Inc., Shimadzu Corporation, Toshiba Medical Systems
Corporation, FUJIFILM Holdings Corporation, Hitachi Medical Corporation,
Koninklijke Philips, Hologic, Inc., General Electric Company, and others.
Related Reports:
Holographic Imaging
Americas Gold Nanoparticles
Automated Suturing Devices
Throat Lozenges
Suture wire
Bionic Eye
For More Information, Please Visit @ Market Research Future
Comments
Post a Comment